RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Privium Fund Management B.V.'s Holding History (CIK: 0001795097)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 119,000 Value ($000) $581 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 119,000 Value ($000) $610 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 119,000 Value ($000) $630 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 119,000 Value ($000) $804 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 78,000 Value ($000) $514 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 52,000 Value ($000) $372 Avg Close $8.72 Range $6.75 - $10.66